Investing Profile

Albert Cha

InvestorVC
Managing Partner at Frazier Healthcare Partners
Photo of Albert Cha, Managing Partner at Frazier Healthcare Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
23
CompanyStageDateRound SizeTotal Raised
Scorpion Therapeutics
Series CJul 2024$150M
$420M
Co-investors: Paulina Hill (Polaris Partners), Arjun Goyal (Vida Ventures), Jean-François Formela (Atlas Venture)
Egetis Therapeutics AB
Post Ipo EquityOct 2023$16M
$16M
Silence Therapeutics
Post Ipo EquityNov 2021$20M
$20M
Olema Oncology
Series COct 2020$85M
$85M
AirXpanders
Post Ipo EquitySep 2018$15M
Series ESep 2014$1M
Series EJun 2013$9M
Series DApr 2012$11M
Series DJan 2012$10M
$46M
Bristol-Myers Squibb
Post Ipo EquityFeb 2017$80M
$80M
Co-investors: Eric Aguiar (Aisling Capital), Peter Kolchinsky (RA Capital), Gregory Bailey
Aclaris Therapeutics
Series CSep 2015$40M
Series BOct 2014$21M
Series AOct 2012$21M
$82M
Co-investors: Ketan Patel (F-Prime Capital Partners)
Sierra Oncology
Series DApr 2014$60M
$60M
Co-investors: Peter Thompson (OrbiMed), James N. Topper (Frazier Healthcare Partners)